Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Jan;79(927):25–29. doi: 10.1136/pmj.79.927.25

Evaluation and treatment of dyspepsia

M Jones 1
PMCID: PMC1742581  PMID: 12566547

Abstract

Dyspepsia is a common symptom. Dyspeptic symptoms may be caused by a variety of conditions such as peptic ulcer disease, gastro-oesophageal reflux, and malignancy. Most often, however, no cause is identified and dyspepsia is deemed to be functional. While symptom severity does influence frequency of consultation, dyspeptic consulters also differ from non-consulters with respect to symptom perception and anxiety. This highlights the importance of understanding the patient's agenda early in the course of evaluation. Patients over the age of 55 years or with alarm symptoms should be referred for prompt endoscopy. In the absence of other clinically apparent aetiologies, uninvestigated dyspeptics can be either tested and treated for Helicobacter pylori or empirically treated with proton pump inhibitors. Uninvestigated dyspeptics failing empiric therapy should be referred for evaluation that includes endoscopy. Further therapy with prokinetics, tricyclic antidepressants, fundal relaxants, antidepressants, or psychotherapy is guided by predominant symptoms and assessment of possible psychiatric factors.

Full Text

The Full Text of this article is available as a PDF (122.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell N. J., Burget D., Howden C. W., Wilkinson J., Hunt R. H. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;51 (Suppl 1):59–67. doi: 10.1159/000200917. [DOI] [PubMed] [Google Scholar]
  2. Blum A. L., Talley N. J., O'Moráin C., van Zanten S. V., Labenz J., Stolte M., Louw J. A., Stubberöd A., Theodórs A., Sundin M. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med. 1998 Dec 24;339(26):1875–1881. doi: 10.1056/NEJM199812243392602. [DOI] [PubMed] [Google Scholar]
  3. Brown C., Rees W. D. Dyspepsia in general practice. BMJ. 1990 Mar 31;300(6728):829–830. doi: 10.1136/bmj.300.6728.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B., Malchow-Møller A. Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol. 1997 Feb;32(2):118–125. doi: 10.3109/00365529709000181. [DOI] [PubMed] [Google Scholar]
  5. Cutler A. F., Havstad S., Ma C. K., Blaser M. J., Perez-Perez G. I., Schubert T. T. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995 Jul;109(1):136–141. doi: 10.1016/0016-5085(95)90278-3. [DOI] [PubMed] [Google Scholar]
  6. Dobrilla G., Comberlato M., Steele A., Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol. 1989 Apr;11(2):169–177. doi: 10.1097/00004836-198904000-00011. [DOI] [PubMed] [Google Scholar]
  7. Drossman D. A., Li Z., Andruzzi E., Temple R. D., Talley N. J., Thompson W. G., Whitehead W. E., Janssens J., Funch-Jensen P., Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569–1580. doi: 10.1007/BF01303162. [DOI] [PubMed] [Google Scholar]
  8. Faigel D. O., Childs M., Furth E. E., Alavi A., Metz D. C. New noninvasive tests for Helicobacter pylori gastritis. Comparison with tissue-based gold standard. Dig Dis Sci. 1996 Apr;41(4):740–748. doi: 10.1007/BF02213130. [DOI] [PubMed] [Google Scholar]
  9. Fisher R. S., Parkman H. P. Management of nonulcer dyspepsia. N Engl J Med. 1998 Nov 5;339(19):1376–1381. doi: 10.1056/NEJM199811053391907. [DOI] [PubMed] [Google Scholar]
  10. Greenberg R. E., Bank S. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age. Arch Intern Med. 1990 Oct;150(10):2053–2055. [PubMed] [Google Scholar]
  11. Holtmann G., Gschossmann J., Neufang-Hüber J., Gerken G., Talley N. J. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut. 2000 Sep;47(3):332–336. doi: 10.1136/gut.47.3.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jones R. H., Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther. 1997 Jun;11(3):541–546. doi: 10.1046/j.1365-2036.1997.00179.x. [DOI] [PubMed] [Google Scholar]
  13. Jones R. Dyspeptic symptoms in the community. Gut. 1989 Jul;30(7):893–898. doi: 10.1136/gut.30.7.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lam S. K., Talley N. J. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998 Jan;13(1):1–12. doi: 10.1111/j.1440-1746.1998.tb00537.x. [DOI] [PubMed] [Google Scholar]
  15. Langeluddecke P., Goulston K., Tennant C. Psychological factors in dyspepsia of unknown cause: a comparison with peptic ulcer disease. J Psychosom Res. 1990;34(2):215–222. doi: 10.1016/0022-3999(90)90055-9. [DOI] [PubMed] [Google Scholar]
  16. Lydeard S., Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract. 1989 Dec;39(329):495–498. [PMC free article] [PubMed] [Google Scholar]
  17. Malagelada J. R., Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology. 1985 May;88(5 Pt 1):1223–1231. doi: 10.1016/s0016-5085(85)80083-4. [DOI] [PubMed] [Google Scholar]
  18. Mason I., Millar L. J., Sheikh R. R., Evans W. M., Todd P. L., Turbitt M. L., Taylor M. D. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Aliment Pharmacol Ther. 1998 Mar;12(3):263–271. doi: 10.1046/j.1365-2036.1998.00282.x. [DOI] [PubMed] [Google Scholar]
  19. Nyrén O., Adami H. O., Gustavsson S., Löf L., Nyberg A. Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol Suppl. 1985;109:41–47. doi: 10.3109/00365528509103934. [DOI] [PubMed] [Google Scholar]
  20. Salet G. A., Samsom M., Roelofs J. M., van Berge Henegouwen G. P., Smout A. J., Akkermans L. M. Responses to gastric distension in functional dyspepsia. Gut. 1998 Jun;42(6):823–829. doi: 10.1136/gut.42.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Simplot T. C., Hoffman H. T. Comparison between cartilage and soft tissue ear piercing complications. Am J Otolaryngol. 1998 Sep-Oct;19(5):305–310. doi: 10.1016/s0196-0709(98)90003-5. [DOI] [PubMed] [Google Scholar]
  22. Soykan I., Lin Z., Jones S., Chen J., McCallum R. W. Gastric myoelectrical activity, gastric emptying and correlations with dyspepsia symptoms in patients with gastroesophageal reflux. J Investig Med. 1997 Oct;45(8):483–487. [PubMed] [Google Scholar]
  23. Stanghellini V., Tosetti C., Paternico A., Barbara G., Morselli-Labate A. M., Monetti N., Marengo M., Corinaldesi R. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996 Apr;110(4):1036–1042. doi: 10.1053/gast.1996.v110.pm8612991. [DOI] [PubMed] [Google Scholar]
  24. Tack J., Caenepeel P., Fischler B., Piessevaux H., Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001 Sep;121(3):526–535. doi: 10.1053/gast.2001.27180. [DOI] [PubMed] [Google Scholar]
  25. Tack J., Coulie B., Wilmer A., Andrioli A., Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut. 2000 Apr;46(4):468–473. doi: 10.1136/gut.46.4.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tack J., Piessevaux H., Coulie B., Caenepeel P., Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998 Dec;115(6):1346–1352. doi: 10.1016/s0016-5085(98)70012-5. [DOI] [PubMed] [Google Scholar]
  27. Talley N. J., Axon A., Bytzer P., Holtmann G., Lam S. K., Van Zanten S. Management of uninvestigated and functional dyspepsia: a Working Party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther. 1999 Sep;13(9):1135–1148. doi: 10.1046/j.1365-2036.1999.00584.x. [DOI] [PubMed] [Google Scholar]
  28. Talley N. J., Fett S. L., Zinsmeister A. R., Melton L. J., 3rd Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994 Oct;107(4):1040–1049. doi: 10.1016/0016-5085(94)90228-3. [DOI] [PubMed] [Google Scholar]
  29. Talley N. J., Fung L. H., Gilligan I. J., McNeil D., Piper D. W. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology. 1986 Apr;90(4):886–892. doi: 10.1016/0016-5085(86)90864-4. [DOI] [PubMed] [Google Scholar]
  30. Talley N. J., Meineche-Schmidt V., Paré P., Duckworth M., Räisänen P., Pap A., Kordecki H., Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov;12(11):1055–1065. doi: 10.1046/j.1365-2036.1998.00410.x. [DOI] [PubMed] [Google Scholar]
  31. Talley N. J., Silverstein M. D., Agréus L., Nyrén O., Sonnenberg A., Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998 Mar;114(3):582–595. doi: 10.1016/s0016-5085(98)70542-6. [DOI] [PubMed] [Google Scholar]
  32. Talley N. J., Stanghellini V., Heading R. C., Koch K. L., Malagelada J. R., Tytgat G. N. Functional gastroduodenal disorders. Gut. 1999 Sep;45 (Suppl 2):II37–II42. doi: 10.1136/gut.45.2008.ii37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Talley N. J., Vakil N., Ballard E. D., 2nd, Fennerty M. B. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999 Oct 7;341(15):1106–1111. doi: 10.1056/NEJM199910073411502. [DOI] [PubMed] [Google Scholar]
  34. Talley N. J., Weaver A. L., Zinsmeister A. R. Impact of functional dyspepsia on quality of life. Dig Dis Sci. 1995 Mar;40(3):584–589. doi: 10.1007/BF02064375. [DOI] [PubMed] [Google Scholar]
  35. Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr;102(4 Pt 1):1259–1268. [PubMed] [Google Scholar]
  36. Tebaldi M., Heading R. C. Clinical economics review: functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther. 1998 Jan;12(1):11–19. doi: 10.1046/j.1365-2036.1998.00261.x. [DOI] [PubMed] [Google Scholar]
  37. Veldhuyzen van Zanten S. J., Cleary C., Talley N. J., Peterson T. C., Nyrén O., Bradley L. A., Verlinden M., Tytgat G. N. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol. 1996 Apr;91(4):660–673. [PubMed] [Google Scholar]
  38. Whitehead W. E., Palsson O. S. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology. 1998 Nov;115(5):1263–1271. doi: 10.1016/s0016-5085(98)70099-x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES